# Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

> **NCT02794805** · PHASE2 · COMPLETED · sponsor: **Meridian Bioscience, Inc.** · enrollment: 74 (actual)

## Conditions studied

- Hepatocellular Carcinoma (HCC)

## Interventions

- **DEVICE:** ¹³C-Octanoate Breath Test

## Key facts

- **NCT ID:** NCT02794805
- **Lead sponsor:** Meridian Bioscience, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2017-03
- **Final completion:** 2017-04
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02794805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02794805, "Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02794805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*